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Abstract
This contribution presents an approach to diagnosis in patients known to have malignant disease, who present
with neurological symptoms and signs which may be a result of epidural spinal cord compression or intradural
spinal disease.
Introduction
Neurological complications in patients with known
malignant disease appear to be increasing in frequency.
It is possible that this is simply a result of more effective
treatment resulting in prolonged survival, allowing more
metastases to develop at all sites. Alternatively, it is
possible that the central nervous system (CNS) acts a
sanctuary site for malignant cells from common solid
tumours [1]. The effects of metastatic disease on the CNS
can be severely disabling. The brain and spinal cord are
enclosed in bone and relatively small volume disease can
have a disproportionately damaging effect. In addition,
the CNS lacks lymphatics so that oedema and biological
detritus are difficult to remove [1]. In the patient with
known malignancy, there is a variety of mechanisms
which can affect the CNS and neurological symptoms
in the cancer patient can be complex. For these reasons,
the approach to imaging differs in some ways from that
used in the previously well patient presenting with an
acute neurological emergency (although it may transpire
that such an emergency is the first manifestation of
disseminated malignancy).
The more frequent spinal manifestations of malignan-
cies are discussed below.
Epidural spinal cord compression
Cord compression is most frequently a result of
metastasis in the vertebral body. A soft tissue mass may
also extend from the posterior elements of the vertebrae,
or from a paravertebral soft tissue mass invading through
the neural foramen. The symptoms of cord compression
in approximate order of frequency and importance are
pain, power loss, sphincter disturbance and a sensory
level. Pain is usually local or radicular, but may be
funicular. Weakness begins in the legs regardless of the
level of compression, and early in the development of
symptoms is more marked proximally. Typical signs
of upper motor neurone weakness, such as spasticity
and hyper-reflexia, may be absent early in the clinical
course [2,3]. In the patient with malignant disease, there
may be more than one level, and compression of the
lower motor neurones below the level of the conus may
mask upper motor neurone signs from a cord compression
more cranially. Sensory levels at the time of clinical
presentation are frequently several segments below the
actual level of compression.
For these reasons it is important to image the entire
spine from sacrum to foramen magnum in all patients
with suspected malignant cord compression [4–6]. MRI
is the technique of choice, and sequence selection
ideally includes sagittal T2-weighted and T1-weighted
spin-echo sequences. If the patient is in pain and
potentially unable to tolerate a full examination, the first
manoeuvre should be to image the entire spine using the
fastest reliable sequence. T1-weighted spin-echo imaging
gives good contrast between tumour and normal bone
marrow, and demonstrates the majority of epidural cord
compressions. The second important principle is that any
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Figure 1 (a) Midline sagittal T1-weighted MRI shows a metastasis in the lower thoracic spine (T10). There is
some epidural soft tissue, although this image does not confirm cord compression. Under these circumstances,
orthogonal plane imaging should be undertaken. (b) Axial T2-weighted sequence shows epidural soft tissue
disease extending from the posterior elements to the left of the midline. The cord is displaced to the right. The
soft tissue component of disease frequently responds to radiotherapy, with resulting clinical improvement.
(a)
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Figure 2 (a) Sagittal T1-weighted image of lumbar region. The meninges show possible minimal thickening.
(b) Gadolinium-enhanced sagittal T1-weighted image. Because the patient had diffuse back pain and mixed
neurological signs, meningeal metastatic disease was suspected. Gadolinium-enhanced imaging demonstrates
thickening and nodularity of the meninges in the lumbar region and around the distal cord (metastases from
carcinoma of breast).
subtle abnormality detected on sagittal imaging should
be interrogated with orthogonal plane imaging, which
may demonstrate a soft tissue mass encroaching on the
lateral aspects of the cord (Fig. 1). It is less important to
interrogate obvious compressive lesions.
The blood supply of the spinal cord is also an important
consideration. The anterior spinal artery is the main
blood supply of the anterior part of the cord and runs
in close proximity to the vertebral body. Anatomically
unspectacular disease may cause the clinical syndrome
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of cord compression by compromising the anterior spinal
artery, resulting in infarction of the cord [2].
Meningeal metastatic disease
In the cancer patient, epidural cord compression by bony
metastasis is the commonest myelopathic presentation.
However, if the history is atypical and neurological signs
do not fit with a discrete site of disease, meningeal
metastatic disease should be considered. It is rarely the
initial manifestation of metastatic disease, and may occur
as a result of haematogenous spread, direct infiltration
through neural foraminae (although the dura is relatively
resistant to the passage of tumour), or as a result of
drop metastases against a background of treated or
untreated cerebral deposits. The most important aspect
in diagnosis is to recognise the possibility clinically:
the unenhanced T2 and T1-weighted sequences may
be entirely normal or show subtle abnormalities. If the
possibility is recognised, intravenous gadolinium is used
to demonstrate the typical appearance [2,7]. Meningeal
disease can be diagnosed with confidence if there are
enhancing nodules or lumps (Fig. 2). Enhancement
of the spinal meninges should always be considered
abnormal, although linear enhancement is more difficult
to interpret following lumbar puncture or therapeutic
intervention such as brain surgery or radiotherapy.
Sensitivity of gadolinium-enhanced MRI for detection
of meningeal disease is far from 100% [8], but is
higher in detection of metastases from common solid
tumours than in meningeal leukaemia or lymphoma.
The commonest malignancies to metastasise to the
meninges are leukaemia and lymphoma, breast, lung and
melanoma [2].
Spinal cord deposits
As with meningeal metastatic disease, lesions in the cord
itself may present with an atypical history and confusing
neurological signs. Gadolinium enhancement is neces-
sary to make the diagnosis with confidence [9], and intra-
axial deposits may be demonstrated when Gadolinium
is given for suspected meningeal metastatic disease.
Once again, breast, lung and melanoma are among the
commonest lesions to metastasise to the spinal cord.
Key points
(1) Neurological presentations are increasing in fre-
quency and are clinically challenging problems in
the cancer patient.
(2) MRI is the investigation of choice for suspected
epidural cord compression and should include the
whole spine.
(3) Craniospinal meningeal metastatic disease results
in symptoms and signs which cannot be attributed
to a single anatomical site.
(4) Intra-axial spinal cord deposits may also present
with atypical features, and both diagnoses are
best made with gadolinium-enhanced T1-weighted
imaging.
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